Aer Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD (NCT06731959) | Aer Therapeutics | 2024-12-01 |
| Single and Multiple Ascending Dose Study of AER-01 (NCT05862623) | Aer Therapeutics | 2023-05-26 |
Track Aer Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.